John Deanfield

602 total citations
15 papers, 87 citations indexed

About

John Deanfield is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, John Deanfield has authored 15 papers receiving a total of 87 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Oncology. Recurrent topics in John Deanfield's work include Chemotherapy-induced cardiotoxicity and mitigation (8 papers), Cardiac Imaging and Diagnostics (6 papers) and Cardiovascular Disease and Adiposity (5 papers). John Deanfield is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (8 papers), Cardiac Imaging and Diagnostics (6 papers) and Cardiovascular Disease and Adiposity (5 papers). John Deanfield collaborates with scholars based in United Kingdom, United States and Denmark. John Deanfield's co-authors include Edward Nicol, David E. Newby, Keith M. Channon, Michael Sweeting, Michael Peake, Mark de Belder, Catherine Welch, David Adlam, Nicolò Matteo Luca Battisti and Alistair Ring and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and European Heart Journal.

In The Last Decade

John Deanfield

13 papers receiving 87 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Deanfield United Kingdom 5 52 30 21 15 11 15 87
Emily Li United States 3 39 0.8× 23 0.8× 17 0.8× 38 2.5× 9 0.8× 3 76
Dan Tesloianu Romania 5 70 1.3× 13 0.4× 9 0.4× 18 1.2× 46 4.2× 15 130
Gregory Jackson United States 5 62 1.2× 25 0.8× 8 0.4× 11 0.7× 9 0.8× 9 103
Junya Ako Japan 4 31 0.6× 12 0.4× 7 0.3× 12 0.8× 32 2.9× 8 96
Álvaro García‐Osuna Spain 7 80 1.5× 25 0.8× 6 0.3× 5 0.3× 33 3.0× 23 148
Stijn A. Bos United States 5 21 0.4× 6 0.2× 13 0.6× 10 0.7× 16 1.5× 5 99
Mehrdad Rabiee Rad Iran 6 42 0.8× 9 0.3× 27 1.3× 16 1.1× 14 1.3× 23 128
Luigi Falco Italy 7 86 1.7× 13 0.4× 8 0.4× 9 0.6× 29 2.6× 20 156
Kazumiki Nomoto Japan 7 62 1.2× 19 0.6× 7 0.3× 13 0.9× 38 3.5× 15 125

Countries citing papers authored by John Deanfield

Since Specialization
Citations

This map shows the geographic impact of John Deanfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Deanfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Deanfield more than expected).

Fields of papers citing papers by John Deanfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Deanfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Deanfield. The network helps show where John Deanfield may publish in the future.

Co-authorship network of co-authors of John Deanfield

This figure shows the co-authorship network connecting the top 25 collaborators of John Deanfield. A scholar is included among the top collaborators of John Deanfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Deanfield. John Deanfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Abiodun, Aderonke, Chengsheng Ju, Catherine Welch, et al.. (2025). Fluoropyrimidine Chemotherapy and the Risk of Death and Cardiovascular Events in Patients With Gastrointestinal Cancer. JACC CardioOncology. 7(4). 345–356. 3 indexed citations
2.
Kushner, Robert F., Donna H. Ryan, John Deanfield, et al.. (2025). Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial. Obesity. 33(3). 452–462. 7 indexed citations
3.
Brown‐Frandsen, Kirstine, Helen M. Colhoun, John Deanfield, et al.. (2024). Semaglutide and cardiovascular outcomes in patients with overweight or obesity who do not have diabetes. Obesity Research & Clinical Practice. 18(5). S36–S36. 1 indexed citations
4.
Plutzky, Jorge, Paweł Bogdański, Selçuk Dağdelen, et al.. (2024). Semaglutide, inflammatory markers and cardiovascular outcomes in patients with overweight or obesity in the select trial. Atherosclerosis. 395. 118518–118518. 1 indexed citations
5.
6.
Abiodun, Aderonke, Chengsheng Ju, Catherine Welch, et al.. (2024). Association of pre-existing cardiovascular disease with administration of fluoropyrimidine chemotherapy in patients with gastrointestinal malignancies. SHILAP Revista de lepidopterología. 3(1). e000323–e000323. 1 indexed citations
7.
Verma, Subodh, John Deanfield, Yaron Arbel, et al.. (2024). Abstract 4141117: Semaglutide and cardiovascular outcomes by blood pressure in the SELECT trial. Circulation. 150(Suppl_1). 1 indexed citations
8.
9.
Teece, Lucy, Michael Sweeting, Marlous Hall, et al.. (2023). Impact of a Prior Cancer Diagnosis on Quality of Care and Survival Following Acute Myocardial Infarction: Retrospective Population-Based Cohort Study in England. Circulation Cardiovascular Quality and Outcomes. 16(6). e009236–e009236. 4 indexed citations
10.
Battisti, Nicolò Matteo Luca, Catherine Welch, Michael Sweeting, et al.. (2022). Prevalence of Cardiovascular Disease in Patients With Potentially Curable Malignancies. JACC CardioOncology. 4(2). 238–253. 27 indexed citations
11.
Channon, Keith M., David E. Newby, Edward Nicol, & John Deanfield. (2022). Cardiovascular computed tomography imaging for coronary artery disease risk: plaque, flow and fat. Heart. 108(19). 1510–1515. 26 indexed citations
12.
Battisti, Nicolò Matteo Luca, Catherine Welch, Mark deBelder, et al.. (2021). 1831P Prevalence of cardiovascular disease in patients diagnosed with six common curable malignancies: A Virtual Cardio-Oncology Research Institute (VICORI) national registry dataset analysis. Annals of Oncology. 32. S1239–S1239. 1 indexed citations
13.
Sweeting, Michael, Clare Oliver‐Williams, Lucy Teece, et al.. (2021). Data Resource Profile: The Virtual Cardio-Oncology Research Initiative (VICORI) linking national English cancer registration and cardiovascular audits. International Journal of Epidemiology. 50(6). 1768–1779. 10 indexed citations
14.
Marwan, Mohamed, Cheerag Shirodaria, Stefan Neubauer, et al.. (2021). Standardised quantification of coronary inflammation using cardiac computed tomography: The Fat Attenuation Index Score (FAI-Score). European Journal of Preventive Cardiology. 28(Supplement_1). 4 indexed citations
15.
Kotanidis, Christos P., Rafail A. Kotronias, Muhammad Siddique, et al.. (2020). Abstract 16467: A Novel CT-derived Radiotranscriptomic Signature of Perivascular Adipose Tissue Stratifies COVID-19 Vascular Cytokine Burst and Predicts in Hospital Outcomes. Circulation. 142(Suppl_3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emily Li Breakdown of academic impact, for papers by Dan Tesloianu Breakdown of academic impact, for papers by Gregory Jackson Breakdown of academic impact, for papers by Junya Ako Breakdown of academic impact, for papers by Álvaro García‐Osuna Breakdown of academic impact, for papers by Stijn A. Bos Breakdown of academic impact, for papers by Mehrdad Rabiee Rad Breakdown of academic impact, for papers by Luigi Falco Breakdown of academic impact, for papers by Kazumiki Nomoto
Rankless by CCL
2026